
Pandorum Technologies
Building blocks of life
Bangalore, India · Founded 2011
- Headquarters
- Bangalore
- Founded
- 2011
- Website
- pandorum.com
- Last Round
- Series BFeb 2026
- Rounds
- 6
About
Pandorum Technologies is a tissue engineering and regenerative medicine company that uses the foundational and translational principles of biology and engineering to design therapeutic products for patients suffering from corneal dystrophies, lung-related disorders, and liver diseases. Founded in 2011 from India's top academic institutions, the company has built proprietary platform technologies in stem cell-derived exosomes and 3D functional tissue fabrication using self-assembly, 3D printing, and bio-materials. Its product pipeline includes a bioengineered cornea, a 3D human liver organoid platform for drug discovery, and cell-free exosomal therapies for lung regeneration. Pandorum operates R&D labs in Bangalore, India and the San Francisco Bay Area, and has been supported by BIRAC, IAN Fund, and top Indian venture capitalists.
Summary
Pandorum Technologies is a Biotech company based in Bangalore, India, founded in 2011. Its most recent funding was a Series B round in Feb 2026. Investors include Wingman Ventures, 021 Capital and Ashish Kacholia.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2026
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company